News

Agriculture and construction equipment maker Deere & Co. (NYSE: DE) reported its fiscal 2023 fourth-quarter results Wednesday morning, and the stock plunged. As of 11:40 a.m. ET, it was down by

Cathie Wood has been surprisingly quiet on the trading front lately. The Ark Invest co-founder and CEO refrained from making any buys or sells for three consecutive trading days before finally

Shares of Amazon (NASDAQ: AMZN) gave up 1.5% of their value on Tuesday, but are getting all those losses back -- and more -- on Wednesday morning, rising 2.1% through 10:45 a.m. ET.

The e-commerce

In this video, I will go over DLocal's (NASDAQ: DLO) third-quarter earnings report. The company missed on both top and bottom lines and has announced that the current CFO is stepping down. This is

Amazon (NASDAQ: AMZN) will start listing Hyundai vehicles on its site starting next year, and that could give the company footing in the auto business. It's not just auto sales Amazon is interested

Image source: The Motley Fool.

Baozun (NASDAQ: BZUN)Q3 2023 Earnings CallNov 22, 2023, 6:30 a.m. ET

Operator

Continue reading

Source Fool.com

Investors were delighted when Sea Limited's (NYSE: SE) e-commerce business, Shopee, reported its first quarter of positive earnings before interest, tax, depreciation, and amortization (EBITDA) at

Retail stocks are having a tough year. That's because consumer spending patterns have slowed in 2023, especially around discretionary purchases like home furnishings and electronics. The shift

Crocs (NASDAQ: CROX), the maker of those popular foam clogs, reported revenue of more than $1 billion and diluted earnings per share (EPS) of $2.87 in the three-month period that ended Sept. 30.

A key reason investors have been bearish on Verizon (NYSE: VZ) is because of its disappointing growth rate. And in an inflationary environment that drives up costs, it's a hard place to be in. But

One of the biggest reasons behind Amazon's (NASDAQ: AMZN) success is the attractiveness of its Prime membership. More than 200 million people have signed up for it. When you consider the value it

Every quarter, hedge funds are required to file a 13-F showing their buys and sells for the quarter. These hedge funds handle huge amounts of money from some of the wealthiest people. Big money is

Investing for retirement can be intimidating, especially if your goal is to have at least $1 million saved when you retire. Most people opt to buy index funds because they don't feel like they know

Analysts on Wall Street sometimes assign one-year price targets to stocks that imply massive upside potential. That's what's happening with Recursion Pharmaceuticals (NASDAQ: RXRX), an innovative

Zoom Video Communications (NASDAQ: ZM) posted its latest earnings report on Nov. 20. For the third quarter of fiscal 2024, which ended on Oct. 31, the video conferencing company's revenue rose 3%

In this video, I will talk about Nvidia's (NASDAQ: NVDA) third-quarter earnings, explain why we have seen its stock soar close to 240% this year, and talk about the dangers ahead. The markets are

If there's one thing every investor learns, eventually, it's that the market goes both up and down. The swings can be dramatic and swift as Wall Street shifts between periods of greed and fear. For

Coca-Cola (NYSE: KO) stock captures a lot of market attention. It's one of Warren Buffett's favorite stocks, it's a classic Dividend King, and Coca-Cola's products are ubiquitous across most of the

Amazon (NASDAQ: AMZN) looks like it's back in action after several quarters of sluggish growth and its first annual loss in a decade in 2022. It's a perennial investor favorite, and there's good

Cisco Systems (NASDAQ: CSCO) and Microsoft (NASDAQ: MSFT) are both blue-chip technology stocks that usually generate stable returns for long-term investors. But over the past three years, Cisco's

Even among the pool of soaring growth stocks, Microsoft (NASDAQ: MSFT) stands out as an outsized winner in this market. The software giant, which sports a $2.8 trillion market capitalization, has

Weight-loss drugs present an enormous opportunity in the healthcare market. Wegovy and Mounjaro are some of the top-selling drugs available in that indication, and companies that make them -- Novo